Dublin-based biotech outfit Inflazome has been acquired for €380 million by Swiss drug company Roche
Dnia irlandzki portal thejournal.ie opublikował artykuł
pod tytułem: "Dublin-based biotech outfit Inflazome has been acquired for €380 million by Swiss drug company Roche",
w którym piszą, że
"IRISH BIOTECH COMPANY Inflazome has been acquired by Swiss drug giant Roche for €380 million. The Dublin-headquartered company, co-founded in 2016 by Trinity College immunology and biochemistry pro...".
Zachęcamy do przeczytania wiadomości na stronie portalu thejournal.ie.